Treatment of pulmonary arterial hypertension

N Engl J Med. 2004 Sep 30;351(14):1425-36. doi: 10.1056/NEJMra040291.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Inhalation
  • Antihypertensive Agents / therapeutic use*
  • Calcium Channel Blockers / therapeutic use
  • Diuretics / therapeutic use
  • Drug Therapy, Combination
  • Endothelin Receptor Antagonists
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / therapeutic use*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / mortality
  • Hypertension, Pulmonary / physiopathology
  • Iloprost / therapeutic use
  • Infusions, Intravenous
  • Nitric Oxide / therapeutic use
  • Piperazines / therapeutic use
  • Purines
  • Sildenafil Citrate
  • Sulfones
  • Vasodilator Agents / therapeutic use*

Substances

  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics
  • Endothelin Receptor Antagonists
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Nitric Oxide
  • Sildenafil Citrate
  • Epoprostenol
  • Iloprost